Our site runs on donations to keep it running for free. Please consider donating if you enjoy your experience here!

Fortress Biotech Suspends Preferred Dividend

Fortress Biotech (FBIO) has suspended the cumulative dividend on their 9.375% preferred issue. This issue was originally sold in 11/2017. Friday shares closed at $16.31 with a current yield of 14.4% (before suspension). Common shares closed at $1.80/share.

The press release is here and was released after market hours Friday. We should expect to see a substantial drop in the share price on Monday.

2 thoughts on “Fortress Biotech Suspends Preferred Dividend”

  1. People keep bashing on REIT preferreds. But all of my defaults were other crap. If I stick to what works I make good money.
    No I didn’t own this one but it brings back bad memories.

    1. Hi Martin – this is a micro cap money losing firm that invests in early stage biotech. Yes this is a preferred stock, but I would not put it in a retirement portfolio. Biotech has been absolutely pounded in this market.

      Not comparable to a REIT at all. There is a REIT ARE which focuses in on
      Biotech/lifesicences facilities. Interesting but too focused for me.

Leave a Reply

Your email address will not be published. Required fields are marked *